Intracellular Ca signaling regulates a plethora of cellular functions. A central role in these processes is reserved for the inositol 1,4,5-trisphosphate receptor (IPR), a ubiquitously expressed Ca-release channel, mainly located in the endoplasmic reticulum (ER). Three IPR isoforms (IPR1, IPR2 and IPR3) exist, encoded respectively by ITPR1, ITPR2 and ITPR3. The proteins encoded by these genes are each about 2700 amino acids long and assemble into large tetrameric channels, which form the target of many regulatory proteins, including several tumor suppressors and oncogenes. Due to the important role of the IPRs in cell function, their dysregulation is linked to multiple pathologies. In this review, we highlight the complex role of the IPR in cancer, as it participates in most of the so-called "hallmarks of cancer". In particular, the IPR directly controls cell death and cell survival decisions via regulation of autophagy and apoptosis. Moreover, the IPR impacts cellular proliferation, migration and invasion. Typical examples of the role of the IPRs in these various processes are discussed. The relative levels of the IPR isoforms expressed and their subcellular localization, e.g. at the ER-mitochondrial interface, is hereby important. Finally, evidence is provided about how the knowledge of the regulation of the IPR by tumor suppressors and oncogenes can be exploited to develop novel therapeutic approaches to fight cancer.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/978-3-030-67696-4_11 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!